ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

MEIP MEI Pharma Inc

3.06
0.00 (0.00%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
MEI Pharma Inc MEIP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 3.06 23:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.13 3.06 3.21 3.06 3.06
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
11/4/202407:02BWMEI Pharma Board of Directors Aligns on Strategy to Advance..
11/4/202407:00BWMEI Pharma Reports Initial Data from Clinical Study..
10/4/202407:00BWMEI Pharma to Present at the Stifel 2024 Virtual Targeted..
26/3/202407:00BWMEI Pharma Reports Update from Clinical Study Evaluating..
28/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
21/2/202415:00EDGAR2Form 8-K - Current report
20/2/202416:33EDGAR2Form S-3 - Registration statement under Securities Act of..
13/2/202416:05EDGAR2Form 8-K - Current report
13/2/202416:05BWMEI Pharma Reports Second Quarter Fiscal Year 2024 Results..
17/1/202415:00EDGAR2Form 8-K - Current report
16/1/202416:00BWMEI Pharma to Present Design of Ongoing Clinical Study..
26/12/202316:00EDGAR2Form 8-K - Current report
22/12/202315:00EDGAR2Form 8-K - Current report
20/12/202320:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202320:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:00EDGAR2Form 8-K - Current report
11/12/202315:00EDGAR2Form 8-K - Current report
11/12/202311:00BWMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor..
14/11/202319:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/11/202315:06EDGAR2Form 8-K - Current report
09/11/202315:05BWMEI Pharma Reports First Quarter Fiscal Year 2024 Results..
09/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202316:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/11/202316:02EDGAR2Form DEF 14A - Other definitive proxy statements
08/11/202307:00BWMEI Pharma to Present at the Stifel 2023 Healthcare..
06/11/202315:57BWMEI Pharma Declares Special Cash Dividend of $1.75 Per Share..
03/11/202317:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/11/202308:00BWMEI Pharma Announces Acceptance of Abstract for Presentation..
01/11/202316:20EDGAR2Form SC 13D/A - General statement of acquisition of..
01/11/202316:15EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
01/11/202315:54EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/11/202315:01EDGAR2Form 8-K - Current report
01/11/202308:00BWMEI Pharma Enters into Agreement with Anson Funds and Cable..
27/10/202315:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/10/202318:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202318:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202316:00EDGAR2Form SC 13D/A - General statement of acquisition of..
17/10/202316:33BWMEI Pharma Recommends Stockholders Not to Consent
17/10/202316:28EDGAR2Form DEFC14A - Definitive proxy statement, contested..
13/10/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202316:00EDGAR2Form SC 13D/A - General statement of acquisition of..
12/10/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202318:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202318:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202316:25EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
10/10/202314:00EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
10/10/202309:33EDGAR2Form DEFC14A - Definitive proxy statement, contested..

Su Consulta Reciente

Delayed Upgrade Clock